Sun, Yan

Outcomes in Patients with Poor-Risk Cytogenetics with or without TP53 Mutations Treated with Venetoclax and Azacitidine

Pollyea, D. A., Pratz, K. W., Wei, A. H., Pullarkat, V., Jonas, B. A., Recher, C., Babu, S., Schuh, A. C., Dail, M., Sun, Y., et al. (2022) · Clinical Cancer Research

Acute Myeloid Leukemia ResearchRetinoids in leukemia and cellular processes

Cited by 159

Deep Learning Based Multimodal Progression Modeling for Alzheimer’s Disease

Yang, L., Wang, X., Guo, Q., Gladstein, S., Wooten, D., Li, T., Robieson, W. Z., Sun, Y., Huang, X., & Initiative, F. T. A. D. N. (2021) · Statistics in Biopharmaceutical Research

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 28